November 28, 2014 8:54 PM ET

Biotechnology

Company Overview of Alpha-Beta Technology

Company Overview

As of 2001, Alpha-Beta Technology went out of business. In January 1999, Alpha-Beta Technology, Inc. entered into an Assignment for the Benefit of Creditors to liquidate its assets. As of September 30, 1998, Alpha-Beta Technology, Inc., a development stage company, was developing immune modulation pharmaceutical products composed of complex carbohydrates and was discovering and developing anti-fungal diagnostics and drugs. The company's lead product, Betafectin® PGG-glucan, was a proprietary carbohydrate polymer. In January 1998, Betafectin® was being tested for the prevention of serious infections in upper gastrointestinal surgery patients. In addition, Alpha-Beta had developed a rapid in v...

One Innovation Drive

Worcester, MA 01605

United States

103 Employees

Phone:

508-798-6900

Key Executives for Alpha-Beta Technology

Chief Financial Officer and Vice President of Finance
Age: 62
Chief Operating Officer
Age: 52
Vice President of Operations
Age: 61
Vice President of Antifungal Research and General Manager of Denver Operations
Age: 70
Vice President of Discovery Research
Age: 59
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
StormBio, Inc. United States
Triton Algae Innovations Ltd. United States
Labnetics United States
Western States Biopharmaceuticals, Inc. United States
Algenetix, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Alpha-Beta Technology, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.